Dave's Q2 Beat and Guidance Raise Send Shares Soaring — But Can a $426 Stock Keep Outrunning Its Own Price Targets?

Shares shifted sharply higher as Dave Inc. posted second-quarter results on August 5 that beat Wall Street estimates across the board, then raised its full-year outlook — forcing investors to ask whether the digital banking upstart's growth justifies a stock price that already exceeds most analyst targets.

A Clean Earnings Beat on Every Line That Matters

Dave delivered Q2 revenue of $171 million, up 30% year-over-year, with adjusted EBITDA (operating profit before certain non-cash charges) surging 48% to $76 million — a 44% margin.

Adjusted earnings per share hit $4.12, up 48% from the prior-year quarter , beating the consensus estimate that had sat near $3.44–$3.69. Revenue also topped forecasts. For shareholders, the takeaway is simple: the company is converting growth into profit faster than anyone expected.

Record Customer Additions Signal the Growth Engine Is Accelerating

Dave added 951,000 new members in the quarter, a 32% year-over-year increase, while maintaining customer acquisition costs at $19 — meaning Dave is spending the same to acquire each user even as it signs up far more of them. Monthly Transacting Members reached 3.08 million (up 17%), and ExtraCash originations — the short-term cash advances that drive most revenue — hit $2.3 billion (up 27%). Credit quality is improving too: the 28-day delinquency rate fell 14 basis points to 2.12% , a critical signal that faster growth isn't coming at the cost of riskier lending.

Raised Guidance Puts Management Ahead of the Street — Again

Dave raised its 2026 outlook to $725–$735 million in revenue and $17–$17.50 in adjusted diluted EPS, above consensus estimates. This marks the second consecutive guidance raise after Q1's 47% revenue growth and EPS of $3.64 also surpassed expectations. But investors should note the tradeoff: Dave plans to increase advertising in the second half , which could pressure margins if returns on that spending weaken.

The Stock May Be Running Past Where Analysts Are Willing to Go At $426, Dave trades above every recent price-target upgrade. B. Riley raised to $449, Citizens JMP to $475, and Keefe, Bruyette & Woods to $490 — yet the average analyst target sits at just $342, implying roughly 15% downside.

Short interest stands at 24.2% , meaning nearly a quarter of tradable shares are bet against the stock. The execution is undeniable, but at this price, Dave must keep clearing a bar that rises with every beat.